Pliant Therapeutics (PLRX) Accounts Payables (2019 - 2026)
Pliant Therapeutics (PLRX) reported Accounts Payables of $362000.0 for Q1 2026, down 93.56% year-over-year from $5.6 million in Q1 2025, and down 24.58% quarter-over-quarter from $480000.0 in Q4 2025.
Pliant Therapeutics (PLRX) Accounts Payables (2019 - 2026) Analysis & Trends
Pliant Therapeutics (PLRX) has 8 years of Accounts Payables data on file, last reported at $362000.0 in Q1 2026.
- Accounts Payables for Q1 2026 came in at $362000.0, down 93.56% year-over-year; the trailing twelve-month figure through Mar 2026 was $362000.0 (down 93.56% YoY), and the FY2025 annual result was $480000.0, down 91.95% from the prior year.
- Accounts Payables retreated to $362000.0 in Q1 2026 per PLRX's latest filing, from $480000.0 in the prior quarter.
- Over five years, Accounts Payables peaked at $7.3 million in Q1 2024 and troughed at $362000.0 in Q1 2026.
- A 5-year average of $3.3 million and a median of $3.2 million in 2022 frame the typical range for Accounts Payables.
- The sharpest annual moves came in 2024 and 2026: Accounts Payables jumped 416.35% in 2024, then tumbled 93.56% in 2026.
- A 5-year view of Accounts Payables shows it stood at $1.6 million in 2022, then surged by 186.77% to $4.5 million in 2023, then jumped by 31.54% to $6.0 million in 2024, then sank by 91.95% to $480000.0 in 2025, then slipped by 24.58% to $362000.0 in 2026.
- Business Quant data shows PLRX's Accounts Payables at $362000.0 in Q1 2026, $480000.0 in Q4 2025, and $485000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | 1.05 Mn |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 83.00 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | 8.64 Mn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 489.30 Mn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | 34.55 Mn |
| 10 | Pliant Therapeutics | 71.07 Mn | 71.07 Mn | - | 362,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 362,000.00 |
| Dec 31, 2025 | 480,000.00 |
| Sep 30, 2025 | 485,000.00 |
| Jun 30, 2025 | 1.38 Mn |
| Mar 31, 2025 | 5.62 Mn |
| Dec 31, 2024 | 5.96 Mn |
| Sep 30, 2024 | 6.89 Mn |
| Jun 30, 2024 | 3.25 Mn |
| Mar 31, 2024 | 7.33 Mn |
| Dec 31, 2023 | 4.53 Mn |
| Sep 30, 2023 | 3.36 Mn |
| Jun 30, 2023 | 2.31 Mn |
| Mar 31, 2023 | 1.42 Mn |
| Dec 31, 2022 | 1.58 Mn |
| Sep 30, 2022 | 3.21 Mn |
| Jun 30, 2022 | 3.12 Mn |
| Mar 31, 2022 | 4.68 Mn |
| Dec 31, 2021 | 2.97 Mn |
| Sep 30, 2021 | 2.61 Mn |
| Jun 30, 2021 | 2.76 Mn |